GABAPENTIN

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71610-630
  • Package NDC 71610-630-30
  • Package NDC 71610-630-45
  • Package NDC 71610-630-53
  • Package NDC 71610-630-60
  • Package NDC 71610-630-70
  • Package NDC 71610-630-73
  • Package NDC 71610-630-80
  • Package NDC 71610-630-92
  • Application number ANDA214957
  • SPL ID 12e0dcb9-e210-413b-9c77-cdeccd600e82
  • SPL set ID 17988b64-723c-488d-befd-3e4e4cc44bd2
  • UNII 6CW7F3G59X
  • RxCUI 310434

What the source publishes

Labeler
Aphena Pharma Solutions - Tennessee, LLC
Active ingredients
Gabapentin
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71610-630_12e0dcb9-e210-413b-9c77-cdeccd600e82
{
  "name": "GABAPENTIN",
  "splId": "12e0dcb9-e210-413b-9c77-cdeccd600e82",
  "labels": [
    {
      "setId": "17988b64-723c-488d-befd-3e4e4cc44bd2",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17988b64-723c-488d-befd-3e4e4cc44bd2",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17988b64-723c-488d-befd-3e4e4cc44bd2"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Aphena Pharma Solutions - Tennessee, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (71610-630-30)",
      "package_ndc": "71610-630-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220420"
    },
    {
      "sample": false,
      "description": "45 TABLET in 1 BOTTLE (71610-630-45)",
      "package_ndc": "71610-630-45",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220420"
    },
    {
      "sample": false,
      "description": "60 TABLET in 1 BOTTLE (71610-630-53)",
      "package_ndc": "71610-630-53",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220420"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (71610-630-60)",
      "package_ndc": "71610-630-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220420"
    },
    {
      "sample": false,
      "description": "120 TABLET in 1 BOTTLE (71610-630-70)",
      "package_ndc": "71610-630-70",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220420"
    },
    {
      "sample": false,
      "description": "135 TABLET in 1 BOTTLE (71610-630-73)",
      "package_ndc": "71610-630-73",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220420"
    },
    {
      "sample": false,
      "description": "180 TABLET in 1 BOTTLE (71610-630-80)",
      "package_ndc": "71610-630-80",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220125"
    },
    {
      "sample": false,
      "description": "270 TABLET in 1 BOTTLE (71610-630-92)",
      "package_ndc": "71610-630-92",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220125"
    }
  ],
  "productId": "71610-630_12e0dcb9-e210-413b-9c77-cdeccd600e82",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "71610-630",
  "deaSchedule": null,
  "genericName": "Gabapentin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GABAPENTIN",
      "strength": "800 mg/1"
    }
  ],
  "applicationNumber": "ANDA214957",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20211001",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "unii": [
      "6CW7F3G59X"
    ],
    "rxcui": [
      "310434"
    ],
    "spl_set_id": [
      "17988b64-723c-488d-befd-3e4e4cc44bd2"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "Aphena Pharma Solutions - Tennessee, LLC"
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71610-630_12e0dcb9-e210-413b-9c77-cdeccd600e82"